MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    16-years of Evaluations for Prodromal Parkinson Features in an At-Risk Cohort with Gaucher Disease

    E. Sidransky, E. Ryan, S. Nishimura, N. Tayebi, G. Lopez (Bethesda, MD, USA)

    Objective: To evaluate prodromal features of Parkinson disease in a cohort of "at-risk"  Gaucher patients and GBA1 carriers . Background: Variants in GBA1 mutations are…
  • 2025 International Congress

    VPS13C: a Modifier Gene causing Suboptimal Response to Levodopa in Early-Onset Parkinson’s Disease

    L. Malfer, C. Piat, O. Ross, Z. Niu, E. Benarroch, R. Savica (Jacksonville, USA)

    Objective: To describe a retrospective clinical study of four cases carrying heterozygous pathogenic variants in the VPS13C gene with a clinical diagnosis of Early-Onset Parkinson’s…
  • 2025 International Congress

    The Global Parkinson’s Genetics Program: Expanding the Diversity of Neurological Disorder Data: 2025 Update

    GP2. Parkinson'S_genetics_program (Chevy Chase, USA)

    Objective: To broaden the available data for Parkinson's Disease (PD) and related disorders by integrating genetic data from more than 115,000 participants worldwide through genotyping…
  • 2025 International Congress

    CAP-003, a CNS-targeted IV-delivered AAV Gene Therapy Developed for Patients with Parkinson’s Disease associated with GBA1 Mutations

    K. Mcdowell, R. Ressler, M. Flynn, B. Wheeler, L. Grigoryeva, A. Armendariz, H. Acharya, P. Denis, J. Granados, P. Tchourilov, C. Pedeferri, M. Brandabur, S. Tole, N. Goeden, N. Flytzanis (Thousand Oaks, USA)

    Objective: CAP-003 is a next-generation gene therapy candidate, comprising a novel brain-tropic capsid paired with hGBA1 cargo, that was developed for administration as a single…
  • 2025 International Congress

    Electrophysiological Mapping in Asleep vs. Awake DBS

    P. Kahali, R. Jamiolkowski, B. Reid, M. Willsey, M. Nuese, R. Fanning, V. Buch, M. Ferris (Palo Alto, USA)

    Objective: We report our experience using microelectrode recording (MER) in asleep vs. awake patients for DBS targeting Background: MER has played a crucial role in…
  • 2025 International Congress

    Predictors of Clinical Benefit from Adaptive DBS Compared to Conventional DBS in Parkinson’s Disease

    J. Tanimura, T. Hashimoto (Matsumoto, Japan)

    Objective: To identify patient characteristics predicting adaptive deep brain stimulation (aDBS) superiority over conventional DBS (cDBS) in Parkinson's disease (PD). Background: Adaptive DBS, modulated in…
  • 2025 International Congress

    Rescue GPi DBS for Severe Dyskinesias and Dystonia in Long-Term STN DBS Parkinson’s Patients: A Case Series

    J. Brainer, P. Brainer, A. Brainer, S. Laurentino, R. Bandim, A. Oliveira, M. Cavalcanti, P. Brainer, C. Vidal (Recife, Brazil)

    Objective: Evaluate GPi DBS as a rescue therapy for refractory dyskinesias and dystonia in long-term STN DBS patients. Background: STN DBS effectively reduces medication dependency…
  • 2025 International Congress

    Prevalence of Supine Hypertension in Alpha-Synucleinopathies: a Systematic Review and Meta-Analysis

    V. Arca, PR. Lopes, FL. Westphal Filho, F. Mendes Filho, C. Falcão, J. Parmera (São Paulo, Brazil)

    Objective: We aimed to conduct a systematic review and meta-analysis to assess the prevalence of supine hypertension (SH) in α-synucleinopathies. Background: Alpha-synucleinopathies, including Parkinson’s Disease…
  • 2025 International Congress

    Impact of Sleep Disturbance and Early Morning OFF Symptoms on Health-Related Quality of Life in Advanced Parkinson’s Disease

    R. Pahwa, I. Malaty, K. Chaudhuri, J. Domingos, M. Heisen, P. Arija, D. Mohan, H. Penton, M. Kuharic, A. Lalla, Z. Baldwin, A. Shewale, C. Yan, M. Boeri (Gainesvile, USA)

    Objective: To quantify the impact of sleep disturbance (Sd) and early morning OFF (EMO) symptoms on health-related quality of life (HRQoL) in people with advanced…
  • 2025 International Congress

    Correlation between Orthostatic Hypotension and Cognitive Impairment in Parkinson’s Disease

    M. Zhong, Y. Li, J. Liu (shanghai, China)

    Objective: This study aims to investigate the relationship between OH and cognitive impairment in PD patients using gray matter volume (GMV) analysis. Background: Orthostatic hypotension…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley